SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 155 filers reported holding SERES THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $346 | -2.3% | 61,090 | -3.3% | 0.02% | -4.5% |
| Q4 2022 | $354 | -99.9% | 63,182 | +14.5% | 0.02% | -4.3% |
| Q3 2022 | $354,000 | +84.4% | 55,194 | -1.4% | 0.02% | +91.7% |
| Q2 2022 | $192,000 | -52.5% | 55,959 | -1.5% | 0.01% | -42.9% |
| Q1 2022 | $404,000 | -12.7% | 56,790 | +2.1% | 0.02% | -8.7% |
| Q4 2021 | $463,000 | +27.5% | 55,631 | +6.7% | 0.02% | +21.1% |
| Q3 2021 | $363,000 | -55.6% | 52,156 | +52.1% | 0.02% | -56.8% |
| Q2 2021 | $818,000 | – | 34,301 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |